These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7495967)

  • 1. Development and biochemical characterization of a double-virus-inactivated factor VIII preparation.
    Robinson S; Schwinn H; Josic D; Nur I; Stadler M; Bal F; Gehringer W; Schütz R
    Blood Coagul Fibrinolysis; 1995 Jul; 6 Suppl 2():S40-7. PubMed ID: 7495967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Removal/neutralization of hepatitis A virus during manufacture of high purity, solvent/detergent factor VIII concentrate.
    Lemon SM; Murphy PC; Smith A; Zou J; Hammon J; Robinson S; Horowitz B
    J Med Virol; 1994 May; 43(1):44-9. PubMed ID: 8083647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful clinical use of a plasma-derived, dual virus inactivated factor VII concentrate incorporating solvent-detergent and dry heat treatment.
    Smith MP; Rice KM; Savidge GF
    Thromb Haemost; 1997 Feb; 77(2):406-7. PubMed ID: 9157608
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro and in vivo characterization of a high-purity, solvent/detergent-treated factor VIII concentrate: evidence for its therapeutic efficacy in von Willebrand's disease.
    Mazurier C; De Romeuf C; Parquet-Gernez A; Goudemand M
    Eur J Haematol; 1989 Jul; 43(1):7-14. PubMed ID: 2504619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis A virus sequence detected in clotting factor concentrates associated with disease transmission.
    Robertson BH; Alter MJ; Bell BP; Evatt B; McCaustland KA; Shapiro CN; Sinha SD; Souci JM
    Biologicals; 1998 Jun; 26(2):95-9. PubMed ID: 9811512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A solvent I detergent treated, pasteurised and highly purified factor VIII concentrate.
    Schwinn H; Stadler M; Josic D; Bal F; Gehringer W; Nur I; Schütz R
    Arzneimittelforschung; 1994 Feb; 44(2):188-91. PubMed ID: 8147954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "In vitro" and in animal model studies on a double virus-inactivated factor VIII concentrate.
    Arrighi S; Rossi R; Borri MG; Lesnikov V; Lesnikova M; Franco E; Divizia M; De Santis ME; Bucci E
    Thromb Haemost; 1995 Sep; 74(3):868-73. PubMed ID: 8571312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of F VIII concentrates produced by two methods incorporating double virus inactivation.
    Branović K; Gebauer B; Trescec A; Benko B
    Appl Biochem Biotechnol; 1998 Feb; 69(2):99-111. PubMed ID: 9513991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress in purification of virus-inactivated factor VIII concentrates. Three generations of solvent/detergent treated plasma derivatives.
    Schwinn H; Smith A; Wolter D
    Arzneimittelforschung; 1989 Oct; 39(10):1302-5. PubMed ID: 2514695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of the hepatitis A epidemics in hemophiliacs in Europe.
    Vermylen J; Peerlinck K
    Vox Sang; 1994; 67 Suppl 4():8-11; discussion 24-6. PubMed ID: 7831867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective study of the evaluation of hepatitis C virus infectivity in a high-purity, solvent/detergent-treated factor VIII concentrate: parallel evaluation of other markers for lipid-enveloped and non-lipid-enveloped viruses. The Ad Hoc Study Group of the Fondazione dell'Emofilia.
    Mariani G; Di Paolantonio T; Baklaya R; Morfini M; Mannucci PM
    Transfusion; 1993 Oct; 33(10):814-8. PubMed ID: 8236421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification of factor VIII and von Willebrand factor from human plasma by anion-exchange chromatography.
    Josic D; Schwinn H; Stadler M; Strancar A
    J Chromatogr B Biomed Appl; 1994 Dec; 662(2):181-90. PubMed ID: 7719474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus validation experiments on the production process of OCTAVI SDPlus.
    Biesert L; Lemon S; Suhartono H; Wang L; Rübsamen H
    Blood Coagul Fibrinolysis; 1995 Jul; 6 Suppl 2():S48-54. PubMed ID: 7495968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative Group.
    Mannucci PM; Gdovin S; Gringeri A; Colombo M; Mele A; Schinaia N; Ciavarella N; Emerson SU; Purcell RH
    Ann Intern Med; 1994 Jan; 120(1):1-7. PubMed ID: 7504424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary clinical experience: pharmacokinetics and tolerance of a double-virus-inactivated factor VIII preparation.
    Martinowitz U
    Blood Coagul Fibrinolysis; 1995 Jul; 6 Suppl 2():S84-5. PubMed ID: 7495976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of viral safety of a high-purity human factor VIII concentrate submitted to 2 specific virus inactivation treatments (FANDHI)].
    Ristol P; Gensana M; Fernández J; Massot M; Biescas H; Darling A; Jorquera JI; Vericat F
    Sangre (Barc); 1996 Apr; 41(2):131-6. PubMed ID: 9045353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of inhibitors in previously untreated or minimally treated patients with haemophilia A after exposure to a plasma-derived solvent-detergent factor VIII concentrate.
    Gringeri A; Monzini M; Tagariello G; Scaraggi FA; Mannucci PM;
    Haemophilia; 2006 Mar; 12(2):128-32. PubMed ID: 16476086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large-scale preparation of a highly purified solvent-detergent treated factor VIII concentrate.
    Myers R; Wickerhauser M; Charamella L; Simon L; Nummy W; Brodniewicz-Proba T
    Vox Sang; 1991; 60(3):141-7. PubMed ID: 1907414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of type III von Willebrand's disease with solvent/detergent-treated factor VIII concentrates.
    Gazengel C; Fischer AM; Schlegel N; Rothschild C; Torchet MF; Dautzenberg MD; Aujard Y
    Nouv Rev Fr Hematol (1978); 1988; 30(4):225-7. PubMed ID: 3143100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Von Willebrand factor multimers in virus-inactivated plasmas and F VIII concentrates.
    Budde U; Drewke E
    Beitr Infusionsther Transfusionsmed; 1994; 32():408-14. PubMed ID: 9422121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.